Intronic IGF1R variant causing aberrant splicing, short stature, and neurological impairments
Journal of Molecular Endocrinology · 2025
DOI: 10.1530/jme-25-0002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Molecular Endocrinology, 2025. Verfasst von Liya Kerem und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, Department of Pediatrics, Hadassah Medical Organization, Jerusalem, Israel. Hauptthemen laut MEDLINE: Dwarfism, Growth Disorders, Introns, Nervous System Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Approximately 10% of children born small for gestational age (SGA) fail to achieve catch-up growth, resulting in persistent short stature and eligibility for growth hormone (GH) therapy under established guidelines. Pathogenic variants in insulin-like growth factor 1 receptor (IGF1R) are associated with SGA, syndromic short stature, neurocognitive impairment, and variable responsiveness to GH therapy. This study aimed to characterize the clinical phenotype and elucidate the molecular mechanism underlying a rare intronic variant in IGF1R identified in an affected family. Here, we performed whole-exome sequencing (WES) on a single individual, followed by segregation studies in the family and Sanger sequencing. cDNA studies were pursued to evaluate mis-spliced transcripts. WES of the proband’s affected mother revealed a rare heterozygous variant in IGF1R (NM_000875.5): c.3722+5G>A. Sanger sequencing confirmed segregation of the variant with the affected status in available family members. cDNA analysis showed that the variant results in intronic retention of 134 nucleotides immediately following the penultimate exon of IGF1R. This leads to a frameshift and introduction of a premature truncation codon, supporting the classification of the variant as likely pathogenic. Our study highlights the utility of genetic testing in SGA children with persistent short stature. By characterizing a novel IGF1R intronic variant causing aberrant splicing, we expand the understanding of its clinical spectrum and molecular underpinning. The findings underscore the importance of molecular diagnostics in unexplained short stature and neurodevelopmental disorders and may inform future therapeutic strategies targeting the IGF1R signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Endocrinology, Department of Pediatrics, Hadassah Medical Organization, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel.
- Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada the Hebrew University of Jerusalem, Jerusalem, Israel.
ORCID-Profile: Liya Kerem
Zitieren
APA
Kerem, L., Rips, J., Zaretsky, A., Grundwag, I., Cohen, E., Yanovsky-Dagan, S., & Harel, T. (2025). Intronic IGF1R variant causing aberrant splicing, short stature, and neurological impairments. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-25-0002
Vancouver
Kerem L, Rips J, Zaretsky A, Grundwag I, Cohen E, Yanovsky-Dagan S, et al. Intronic IGF1R variant causing aberrant splicing, short stature, and neurological impairments. Journal of Molecular Endocrinology. 2025. doi:10.1530/jme-25-0002
BibTeX
@article{Kerem2025,
author = {Kerem, Liya and Rips, Jonathan and Zaretsky, Adam and Grundwag, Itay and Cohen, Ehud and Yanovsky-Dagan, Shira and Harel, Tamar},
title = {Intronic IGF1R variant causing aberrant splicing, short stature, and neurological impairments},
journal = {Journal of Molecular Endocrinology},
year = {2025},
doi = {10.1530/jme-25-0002}
}
EUVIMED